Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.40 |
| ▸ | C1S | P09871 | 1/20 | 0.35 |
| ▸ | PARP1 | P09874 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | IDO1 | P14902 | 2/20 | 0.34 |
| ▸ | AGXT | P21549 | 2/20 | 0.34 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | KDM1A | O60341 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28680799 | 0.79 | ALDH1A1 (0.46) | ALDH1A1MAPK1TAAR1C1SPARP1 | |
| SCHEMBL10749139 | 0.75 | ALDH1A1 (0.42) | ALDH1A1MAPK1TAAR1C1SPARP1 | |
| SCHEMBL18860666 | 0.75 | ALDH1A1 (0.42) | ALDH1A1MAPK1TAAR1C1SPARP1 | |
| SCHEMBL20560941 | 0.75 | ALDH1A1 (0.43) | ALDH1A1MAPK1TAAR1C1SIDO1 | |
| SCHEMBL258733 | 0.73 | TDP1 (0.57) | ALDH1A1MAPK1TAAR1C1SPARP1 | |
| Bromide SCHEMBL7090229 | 0.71 | TDP1 (0.55) | ALDH1A1MAPK1C1STDP1IDO1 | |
| SCHEMBL5000 | 0.71 | — | — | |
| SCHEMBL30862120 | 0.70 | ALDH1A1 (0.39) | ALDH1A1MAPK1TAAR1IDO1AGXT | |
| SCHEMBL29449952 | 0.70 | ALDH1A1 (0.39) | ALDH1A1MAPK1TAAR1C1SPARP1 | |
| SCHEMBL28056088 | 0.70 | ACHE (0.48) | MAPK1TAAR1PARP1IDO1AGXT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240147841-A1 | Organic Semiconductive Layer Comprising Phosphine Oxide Compounds | NOVALED GMBH (DE) | 2024-05-02 | — | — | US | disclosed |
| US-11950496-B2 | Organic semiconductive layer comprising phosphine oxide compounds | NOVALED GMBH (DE) | 2024-04-02 | — | — | US | disclosed |
| EP-4194442-A1 | ORGANIC ELECTRONIC DEVICE COMPRISING AN ORGANIC SEMICONDUCTOR LAYER | Novaled GmbH (DE) | 2023-06-14 | — | — | EP | disclosed |
| US-11502258-B2 | Organic electronic device comprising an organic semiconductor layer | NOVALED GMBH (DE) | 2022-11-15 | — | — | US | disclosed |
| WO-2021007477-A1 | INDAZOLES AND AZAINDAZOLES AS LRRK2 INHIBITORS | E-SCAPE BIO, INC. (US) | 2021-01-14 | — | — | WO | disclosed |
| US-20200161559-A1 | Organic Electronic Device Comprising an Organic Semiconductor Layer | NOVALED GMBH (DE) | 2020-05-21 | — | — | US | disclosed |
| US-20180337339-A1 | Organic Semiconductive Layer Comprising Phosphine Oxide Compounds | NOVALED GMBH (DE) | 2018-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240147841-A1 | Organic Semiconductive Layer Comprising Phosphine Oxide Compounds | ALK, OR10J3, CCNT1 | ALDH1A1 1777/4885MAPK1 84/4885TAAR1 557/4885 |
| US-20200161559-A1 | Organic Electronic Device Comprising an Organic Semiconductor Layer | C1S, YAP1, ESR1 | ALDH1A1 1093/4885MAPK1 666/4885TAAR1 1496/4885 |
| US-20180337339-A1 | Organic Semiconductive Layer Comprising Phosphine Oxide Compounds | ALK, OR10J3, C1S | ALDH1A1 1886/4885MAPK1 78/4885TAAR1 537/4885 |
| US-11502258-B2 | Organic electronic device comprising an organic semiconductor layer | C1S, YAP1, ESR1 | ALDH1A1 1093/4885MAPK1 666/4885TAAR1 1496/4885 |
| US-11950496-B2 | Organic semiconductive layer comprising phosphine oxide compounds | ALK, OR10J3, C1S | ALDH1A1 1886/4885MAPK1 78/4885TAAR1 537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.